[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349265-105":59,"doc-detail-349265-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","biomarkers-of-radioresistance-in-lung-cancer-current-insights-and-future-directions-review","Biomarkers of radioresistance in lung cancer - Current insights and future directions - Review","","Radiotherapy (RT) remains a cornerstone of lung cancer management, used either definitively or as an adjuvant after surgical resection. A central obstacle for radiation oncologists is radioresistance, which contributes to therapeutic failure, tumor recurrence, metastasis, and increased patient mortality. Radioresistance is multifactorial, driven by genetic and epigenetic alterations that disrupt key signaling pathways. This review synthesizes molecular evidence on biomarkers linked to RT resistance, supporting patient stratification and precision oncology targeting.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomarkers-of-radioresistance-in-lung-cancer-current-insights-and-future-directions-review/349265/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomarkers-of-radioresistance-in-lung-cancer-current-insights-and-future-directions-review/349265.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is radioresistance a major challenge in lung cancer treatment?","Question",{"text":113,"@type":114},"Radioresistance undermines radiotherapy effectiveness, leading to therapeutic failure, tumor recurrence, metastasis, and higher patient mortality.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What drives radioresistance at the molecular level?",{"text":118,"@type":114},"It is a multifactorial process driven by genetic and epigenetic alterations that dysregulate key signal transduction pathways, allowing cancer cells to survive radiation stress.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the purpose of this review?",{"text":122,"@type":114},"It synthesizes current evidence on molecular biomarkers associated with RT resistance in lung cancer to support patient stratification, prognostication, and therapeutic targeting.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349265,1790848617,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Molecular Medicine rePorTS 34: 204, 2026  \nBiomarkers of radioresistance in lung cancer: Current insights and future directions (Review)  \nFaTiMa ZoHra aTTouaHri1,2 , iMane cHaoui1 , aBdelilaH laraQui3 , MoHaMed rida TaGaJdid3 , MoHaMMed ouKaBli4 , MoHaMMed elMarJanY5 , MerieM KHYaTTi6 , MoHaMMed aTTaleB1 , Mouna aBaBou2 , KHalid enniBi3 , KHaoulaerraFii7 and MoHaMMed elMZiBri1  \n1  \ndepartment of life Sciences, national center for nuclear energy, Sciences and Techniques (cneSTen), rabat 10001, Morocco; 2  \nlaboratory of Biodiversity, ecology and Genome, department of Biology, Faculty of Sciences, Mohammed V university in rabat,  \nrabat 10050, Morocco; 3center of Virology, infectious and Tropical diseases, Mohammed V Military Teaching Hospital, rabat 10100, 4 5  \nMorocco; department of Pathology, Mohammed V Military Teaching Hospital, rabat 10100, Morocco; department of radiation oncology, Mohamed V Military Teaching Hospital, rabat 10100, Morocco; 6laboratory of Genetics, department of research, Pasteur institute of  \n7  \nMorocco, casablanca 20250, Morocco; african Genome centre, Mohammed Vi Polytechnic university, Benguerir 43150, Morocco  \nreceived June 17, 2025; accepted october 29, 2025  \ndoi: 10. 3892/mmr.2026.13914  \nAbstract. radiotherapy (rT) remains a cornerstone of lung cancer (LC) management, serving as either a definitive treat‑ ment or an adjuvant modality following surgical resection . nevertheless, a major challenge for radiation oncologists is the  \nCorrespondence to: dr Mohammed el Mzibri, department of life Sciences, national center for nuclear energy, Sciences and Techniques (cneSTen), avenue Mohamed Ben abdellah, rabat 10001, Morocco  \ne‑[mail: mzibri@yahoo.com](mail: mzibri@yahoo.com)  \nAbbreviations: anGPTl4, angiopoietin‑like 4 protein; ATG16L2 , autophagy related 16 like 2 gene; ca‑iX, carbonic anhydrase iX; coMP, cartilage oligomeric matrix protein; cSc , cancer stem cell; ctdna , circulating tumor dna; ercc1, excision repair cross‑complementation; FaSn, fatty acid synthase; FBln5, fibulin‑5; FloT1, flotillin‑1; FBXo22, F‑box protein 22; Fn1, fibronectin 1; FOLR3, folate receptor‑3; GrP78, glucose‑regulated protein 78; HiF‑1α , hypoxia‑inducible factor 1α; HSP70, heat shock protein 70; HSPB1, heat shock protein β‑1; iASPP, inhibitor of apoptosis‑stimulating protein of p53; icaM‑1, intercellular adhesion molecule 1; KEAP1, Kelch‑like ecH‑associated protein 1; Klc4, kinesin light chain 4; liG4, dna ligase 4; lncrna, long noncoding rna; lScc , lung squamous cell carcinoma; luad, lung adenocarcinoma; NFE2L2 , nuclear factor erythroid 2‑related factor‑2; noMo2, nodal modulator 2; nSclc , non‑small cell lung cancer; oPn, osteopontin; Pai‑2, plasminogen activator inhibitor‑2; Pd‑l1, programmed cell death ligand 1; PFS, progression‑free survival; PKP2, plakophilin 2; Plod3, procollagen‑lysine, 2‑oxoglutarate 5‑dioxygenase 3; raSa2, ras p21 protein activator; rT, radiotherapy; SnP, single nucleotide polymorphism; THBS1, thrombospondin 1; ViM, vimentin; XRCC1, X‑ray repair cross‑complementing protein 1  \nKey words: lung cancer, biomarkers, radioresistance, rT  \nemergence of radioresistance, whether intrinsic or acquired, which contributes to therapeutic failure, tumor recurrence, metastasis and ultimately to increased patient mortality. radioresistance is a multifactorial process driven by genetic and epigenetic alterations that dysregulate key signal trans‑ duction pathways, enabling cancer cells to survive and adapt under radiotherapeutic stress . a deeper understanding of the molecular mechanisms underlying radioresistance is therefore essential to identify robust biomarkers for patient stratification, prognostication and therapeutic targeting. Such insights could enable individualized treatment strate‑ gies within the framework of precision oncology and inform the development of novel radiosensitization approaches to overcome resistance in lc. The present review synthesized current evidence on molecular bio","cbCait14O8bFyzqw","https://ap.wps.com/l/cbCait14O8bFyzqw","pdf",5475256,17,"English","# Introduction\n## Predictive biomarkers in radiation-based personalized medicine for lung cancer\n## Limitations and perspectives\n# Conclusion","[{\"question\":\"Why is radioresistance a major challenge in lung cancer treatment?\",\"answer\":\"Radioresistance undermines radiotherapy effectiveness, leading to therapeutic failure, tumor recurrence, metastasis, and higher patient mortality.\"},{\"question\":\"What drives radioresistance at the molecular level?\",\"answer\":\"It is a multifactorial process driven by genetic and epigenetic alterations that dysregulate key signal transduction pathways, allowing cancer cells to survive radiation stress.\"},{\"question\":\"What is the purpose of this review?\",\"answer\":\"It synthesizes current evidence on molecular biomarkers associated with RT resistance in lung cancer to support patient stratification, prognostication, and therapeutic targeting.\"}]","Biomarkers of radioresistance in lung cancer - Current insights and future directions - Review | PDF",1790082504,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3894b9e1c30538604d8541bf961a4fd.webp",983,1357,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47f729376600db422745b4ff86230c0b.webp",982,1356,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fe981bfb1becf55d8f34eb9e305d1b5.webp",981,1354,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/713110538dcad3385d7079da4c75eae1.webp",980,1353]